209 related articles for article (PubMed ID: 33318230)
1. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
2. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
3. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
Biset A; Claris O
Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
[TBL] [Abstract][Full Text] [Related]
6. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
Kim F; Towers HM
J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
[TBL] [Abstract][Full Text] [Related]
7. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
8. Central diabetes insipidus: alert for dehydration in very low birth weight infants during the neonatal period. A case report.
Ferlin ML; Sales DS; Celini FP; Martinelli Junior CE
Sao Paulo Med J; 2015 Feb; 133(1):60-3. PubMed ID: 25271879
[TBL] [Abstract][Full Text] [Related]
9. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing.
Van der Kaay DC; Van Heel WJ; Dudink J; van den Akker EL
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):769-71. PubMed ID: 24670345
[TBL] [Abstract][Full Text] [Related]
10. Profound hypernatremia due to central diabetes insipidus.
Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib Treatment Was Unsuccessful for Central Diabetes Insipidus Due to Pituitary Metastasis of Lung Adenocarcinoma.
Tanaka S; Hirabayashi T; Kimoto M; Hama M; Hachiya T; Gomi K
Intern Med; 2021 Apr; 60(7):1073-1076. PubMed ID: 33162476
[TBL] [Abstract][Full Text] [Related]
12. Diabetes Insipidus Presenting with Oligohydramnios and Polyuria During Pregnancy.
Choi HS; Kim YH; Kim CS; Ma SK; Kim SW; Bae EH
J Nippon Med Sch; 2018; 85(3):191-193. PubMed ID: 30135348
[TBL] [Abstract][Full Text] [Related]
13. The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics.
Rivkees SA; Dunbar N; Wilson TA
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):459-69. PubMed ID: 17550208
[TBL] [Abstract][Full Text] [Related]
14. Management of central diabetes insipidus.
Garrahy A; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
[TBL] [Abstract][Full Text] [Related]
15. Persistent central diabetes insipidus presenting in a very low birth weight infant successfully managed with intranasal dDAVP.
Stapleton G; DiGeronimo RJ
J Perinatol; 2000 Mar; 20(2):132-4. PubMed ID: 10785891
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
17. Permanent central diabetes insipidus after traumatic brain injury. Case report and literature review.
Astafyeva LI; Sidneva YG; Badmaeva IN; Kalinin PL; Latyshev YA; Marshintsev AV; Valiullina SA
Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(5):112-118. PubMed ID: 36252201
[TBL] [Abstract][Full Text] [Related]
18. Use of subcutaneous DDAVP in infants with central diabetes insipidus.
Blanco EJ; Lane AH; Aijaz N; Blumberg D; Wilson TA
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):919-25. PubMed ID: 16995572
[TBL] [Abstract][Full Text] [Related]
19. Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.
Dubinski I; Bechtold-Dalla Pozza S; Schmidt H
J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1544-1546. PubMed ID: 36240057
[TBL] [Abstract][Full Text] [Related]
20. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
Fjellestad-Paulsen A; Crosnier H; Czernichow P
Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
